Abstract
The current diagnostic pathway for breast cancer is cumbersome as very often two and sometimes three different imaging modalities need to be used to come to a diagnosis. Pathologic assessment of resected tissue specimens is seen as the golden standard and is performed on top of imaging to confirm the diagnosis. A non-invasive imaging modality with a high sensitivity and specificity for all breast lesion types, which can be used as a stand-alone technique and replaces the currently used modalities, can be considered as the holy grail in breast cancer screening and diagnosis. The introduction of such a modality can drastically reduce healthcare costs and also lower the burden to the patient.
Original language | English |
---|---|
Qualification | Doctor of Philosophy |
Awarding Institution |
|
Supervisors/Advisors |
|
Award date | 10 Dec 2021 |
Place of Publication | Enschede |
Publisher | |
Print ISBNs | 978-90-365-5304-9 |
DOIs | |
Publication status | Published - 10 Dec 2021 |